AU1896095A - Recombinant adenoviruses for glial maturation factor beta (gmf-beta ) - Google Patents

Recombinant adenoviruses for glial maturation factor beta (gmf-beta )

Info

Publication number
AU1896095A
AU1896095A AU18960/95A AU1896095A AU1896095A AU 1896095 A AU1896095 A AU 1896095A AU 18960/95 A AU18960/95 A AU 18960/95A AU 1896095 A AU1896095 A AU 1896095A AU 1896095 A AU1896095 A AU 1896095A
Authority
AU
Australia
Prior art keywords
beta
gmf
recombinant adenoviruses
maturation factor
glial maturation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18960/95A
Other languages
English (en)
Inventor
Pascal Barneoud
Pia Delaere
Michel Perricaudet
Laurent Pradier
Emmanuelle Vigne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Publication of AU1896095A publication Critical patent/AU1896095A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU18960/95A 1994-03-18 1995-03-02 Recombinant adenoviruses for glial maturation factor beta (gmf-beta ) Abandoned AU1896095A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9403192 1994-03-18
FR9403192A FR2717497B1 (fr) 1994-03-18 1994-03-18 Virus recombinants, préparation et utilisation en thérapie génique.
PCT/FR1995/000248 WO1995025802A1 (fr) 1994-03-18 1995-03-02 ADENOVIRUS RECOMBINANTS POUR LE FACTEUR DE MATURATION DES CELLULES GLIALES DE TYPE BETA (GMF-β)

Publications (1)

Publication Number Publication Date
AU1896095A true AU1896095A (en) 1995-10-09

Family

ID=9461191

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18960/95A Abandoned AU1896095A (en) 1994-03-18 1995-03-02 Recombinant adenoviruses for glial maturation factor beta (gmf-beta )

Country Status (8)

Country Link
EP (1) EP0750674A1 (fr)
JP (1) JPH09510356A (fr)
AU (1) AU1896095A (fr)
CA (1) CA2184408A1 (fr)
FR (1) FR2717497B1 (fr)
IL (1) IL112994A0 (fr)
WO (1) WO1995025802A1 (fr)
ZA (1) ZA952243B (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270452A (en) * 1988-11-28 1993-12-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Pure glia maturation factor
FR2688514A1 (fr) * 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
WO1994008026A1 (fr) * 1992-09-25 1994-04-14 Rhone-Poulenc Rorer S.A. Vecteurs d'adenovirus pour le transfert de genes etrangers dans des cellules du systeme nerveux central, en particulier du cerveau
FR2704234B1 (fr) * 1993-04-22 1995-07-21 Centre Nat Rech Scient Virus recombinants, preparation et utilisation en therapie genique.

Also Published As

Publication number Publication date
ZA952243B (en) 1996-01-09
EP0750674A1 (fr) 1997-01-02
CA2184408A1 (fr) 1995-09-28
FR2717497B1 (fr) 1996-04-12
WO1995025802A1 (fr) 1995-09-28
JPH09510356A (ja) 1997-10-21
IL112994A0 (en) 1995-06-29
FR2717497A1 (fr) 1995-09-22

Similar Documents

Publication Publication Date Title
AU4370596A (en) Novel hedgehog-derived polypeptides
AU676586B2 (en) Bone transporter
IL116816A0 (en) Recombinant defective adenoviruses
EP0698908A3 (fr) Appareil magnétron
AU688210B2 (en) Recombinant obese (Ob) proteins
AU3447097A (en) Method for producing recombinant adenovirus
AU5283793A (en) Recombinant specific binding protein
AU3891095A (en) X-y-omicron positioning mechanism
EP0698909A3 (fr) Appareil magnétron
AU2142595A (en) Recombinant adenoviruses coding for basic fibroblast growth factors (bfgf)
EP0690494A3 (fr) Technologie pour connecter et construire des modules multi-chip
AU3028995A (en) Binding agent for growth factor
AU2523795A (en) Inhaler
AU679312B2 (en) Apparatus for electro-fishing
AU2131195A (en) Prophenins - antibiotic peptides
EP0702889A3 (fr) Epandeur centrifugal
AU2728395A (en) Dog-food dressing
AU4692396A (en) Anti-inflammatory cd14 polypeptides
AU2728295A (en) Cat-food dressing
AU2120895A (en) Foot analyzer
AU1896195A (en) Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf)
AU8140094A (en) New factor viii polypeptides
AU3860995A (en) Adjusting means
AU1896095A (en) Recombinant adenoviruses for glial maturation factor beta (gmf-beta )
AUPM489194A0 (en) Peptides